Latest filing published 10 Feb 2026 for Dynavax Technologies CORP.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Ryan Spencer (chief executive) discloses dealings in Dynavax Technologies Corp to SEC (Form 4). The record holds 46 filings, for trades running from 2 June 2019 to 10 February 2026.
No open-market purchase appears, only 4 sales worth €1.0M. The rest of the record consists of 20 share grants and 19 option exercises.
The latest filing, published on 10 February 2026, reports a share grant in Dynavax Technologies Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations